PT86870A - Pharmaceutical tablet pharmaceutical granulate and process for their preparation - Google Patents
Pharmaceutical tablet pharmaceutical granulate and process for their preparationInfo
- Publication number
- PT86870A PT86870A PT86870A PT8687088A PT86870A PT 86870 A PT86870 A PT 86870A PT 86870 A PT86870 A PT 86870A PT 8687088 A PT8687088 A PT 8687088A PT 86870 A PT86870 A PT 86870A
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical
- preparation
- granulate
- tablet
- pharmaceutical tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP87200357 | 1987-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT86870A true PT86870A (pt) | 1988-04-01 |
PT86870B PT86870B (pt) | 1992-05-29 |
Family
ID=8197583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT86870A PT86870B (pt) | 1987-03-02 | 1988-03-01 | Processo para a preparacao de um granulado e de um comprimido a base de um antibiotico de beta-lactama |
Country Status (16)
Country | Link |
---|---|
US (1) | US4950484A (pt) |
EP (1) | EP0281200B1 (pt) |
JP (1) | JPS63301820A (pt) |
KR (1) | KR960009182B1 (pt) |
CN (1) | CN1036763C (pt) |
AU (1) | AU603870B2 (pt) |
CA (1) | CA1338467C (pt) |
DE (1) | DE3887179T2 (pt) |
DK (1) | DK175508B1 (pt) |
ES (1) | ES2061623T3 (pt) |
FI (1) | FI94214C (pt) |
IE (1) | IE70907B1 (pt) |
IL (1) | IL85594A (pt) |
NO (1) | NO174996C (pt) |
NZ (1) | NZ223711A (pt) |
PT (1) | PT86870B (pt) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0319074B1 (en) * | 1987-11-30 | 1992-01-29 | Brocades Pharma B.V. | Pharmaceutical composition and process for its preparation |
US5211958A (en) * | 1987-11-30 | 1993-05-18 | Gist-Brocades, N.V. | Pharmaceutical composition and process for its preparation |
ES2060737T3 (es) * | 1988-02-25 | 1994-12-01 | Yamanouchi Europ Bv | Procedimiento de preparacion de un granulado farmaceutico. |
FR2638971B1 (fr) * | 1988-11-15 | 1993-01-08 | Vacher Dominique | Comprime a delitement et/ou dissolution instantane |
US5814337A (en) * | 1992-10-07 | 1998-09-29 | Beecham Group Plc | Pharmaceutical formulation |
GB9007945D0 (en) * | 1990-04-07 | 1990-06-06 | Beecham Group Plc | Pharmaceutical formulation |
CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
DK0481294T4 (da) * | 1990-10-19 | 2001-06-18 | Spirig Ag | Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein |
FR2671970B1 (fr) * | 1991-01-30 | 1995-06-23 | Wellcome Found | Comprimes dispersables dans l'eau. |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5861172A (en) * | 1991-05-08 | 1999-01-19 | Laboratorios Beecham Sa | Pharmaceutical formulations of compacted granulates of β-lactam antibiotics |
GB9109862D0 (en) | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
FR2679451B1 (fr) * | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
GB9215908D0 (en) * | 1992-07-27 | 1992-09-09 | Wellcome Found | Water dispersible tablets |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
ES2079327B1 (es) * | 1994-12-13 | 1996-08-01 | Lilly Sa | Formulaciones farmaceuticas de cefaclor. |
ZA961018B (en) * | 1995-02-08 | 1997-08-08 | Yamanouchi Europ Bv | Oral dosage-forms containing a beta-lactam antibiotic. |
US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
NZ318282A (en) | 1995-09-07 | 2000-01-28 | Smithkline Beecham Corp | Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1 |
CN1136853C (zh) * | 1996-02-29 | 2004-02-04 | 藤泽药品工业株式会社 | 含β-内酰胺抗生素的片剂及其制备方法 |
TWI225402B (en) * | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
AT407214B (de) * | 1996-03-13 | 2001-01-25 | Biochemie Gmbh | Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
US6242006B1 (en) | 1996-07-16 | 2001-06-05 | Gist-Brocades B.V. | β-lactam granules free of organic solvents |
WO1998034598A2 (en) * | 1997-02-07 | 1998-08-13 | Gist-Brocades B.V. | Homogeneous granulated formulations for dose sipping technology |
US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
CN1268888A (zh) * | 1997-08-29 | 2000-10-04 | Dsm公司 | 不含赋形剂的颗粒 |
US6129932A (en) * | 1997-09-05 | 2000-10-10 | Merck & Co., Inc. | Compositions for inhibiting platelet aggregation |
WO1999018965A1 (en) * | 1997-10-10 | 1999-04-22 | Yamanouchi Europe B.V. | Oral compositions containing a cephalosporin antibiotic |
PL334517A1 (en) * | 1997-11-17 | 2000-02-28 | Gist Brocades Bv | Clavulate and one or more of exicipients containing granules |
IL141339A0 (en) * | 1998-09-25 | 2002-03-10 | Delsys Pharmaceutical Corp | Liquid pharmaceutical for oral delivery |
US6692779B2 (en) * | 1999-03-26 | 2004-02-17 | The Pillsbury Company | Food products with biocontrol preservation |
US6294199B1 (en) * | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US20020006433A1 (en) * | 1999-04-29 | 2002-01-17 | Nigel P. Davidson | Pharmaceutical formulations |
US6716453B1 (en) * | 1999-05-20 | 2004-04-06 | Verion, Inc. | Method for increasing the active loading of compressible composition forms |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
AR025587A1 (es) * | 1999-09-13 | 2002-12-04 | Hoffmann La Roche | Formulaciones en dispersion que contienen inhibidores de lipasa |
UY26615A1 (es) * | 2000-03-16 | 2001-10-25 | Pfizer Prod Inc | Inhibidor de la glucogeno fosforilasa. |
FR2814679B1 (fr) * | 2000-09-29 | 2003-04-11 | Cll Pharma | Compositions pharmaceutiques dispersibles a base de cephalosporines, leur procede de preparation et leur utilisation |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US6544552B2 (en) | 2001-01-11 | 2003-04-08 | Particle And Coating Technologies, Inc. | Method of producing porous tablets with improved dissolution properties |
EP1285649A1 (en) * | 2001-08-23 | 2003-02-26 | Cimex AG | Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
RU2004123621A (ru) * | 2002-02-01 | 2005-04-10 | Пфайзер Продактс Инк. (Us) | Лекарственные формы с немедленным высвобождением, содержащие твердые дисперсии лекарств |
EP1488811A1 (en) * | 2002-03-06 | 2004-12-22 | Kyowa Hakko Kogyo Co., Ltd. | Tablets quickly disintegrating in oral cavity |
ATE407674T1 (de) | 2002-04-09 | 2008-09-15 | Flamel Tech Sa | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin |
ATE419840T1 (de) | 2002-04-09 | 2009-01-15 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
US6958161B2 (en) | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
AU2003249116A1 (en) * | 2002-07-16 | 2004-02-02 | Ranbaxy Laboratories Limited | Dispersible tablets for oral administration |
US20070014850A1 (en) * | 2002-08-02 | 2007-01-18 | Ramalingam Manikandan | Process for the preparation of dispersible tablets of cephalexin |
JP2007523125A (ja) * | 2004-02-24 | 2007-08-16 | サンド・アクチエンゲゼルシヤフト | アモキシシリンインスタント顆粒 |
US20050244347A1 (en) * | 2004-04-30 | 2005-11-03 | Mehra Dev K | Oral care products comprising calcium phosphates |
US20070196477A1 (en) * | 2004-04-30 | 2007-08-23 | Withiam Michael C | Rapidly dissolving tablets comprising low surface area calcium phosphates |
US20050244343A1 (en) * | 2004-04-30 | 2005-11-03 | Withiam Michael C | Oral care products comprising silica |
WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
JP5227591B2 (ja) * | 2005-01-07 | 2013-07-03 | サンド・アクチエンゲゼルシヤフト | アモキシシリンを含む粒剤の調製方法 |
GB0516604D0 (en) * | 2005-08-12 | 2005-09-21 | Sandoz Ag | Rapidly dispersing/disintegrating compositions |
JP2010522135A (ja) | 2006-10-09 | 2010-07-01 | チャールストン ラボラトリーズ,インコーポレイテッド | 医薬組成物 |
KR20100033400A (ko) * | 2007-06-06 | 2010-03-29 | 바스프 에스이 | 급속 붕해 정제의 제조를 위한 제약 제제 |
US20090162434A1 (en) * | 2007-12-21 | 2009-06-25 | Disphar International Bv | Mesalazine tablet |
CA3066426A1 (en) | 2008-01-09 | 2009-07-16 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
US8785160B2 (en) | 2009-02-24 | 2014-07-22 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
SG2014014435A (en) | 2009-02-24 | 2014-07-30 | Ritter Pharmaceuticals Inc | Prebiotic formulations and methods of use |
WO2011006012A1 (en) | 2009-07-08 | 2011-01-13 | Charleston Laboratories Inc. | Pharmaceutical compositions |
TR200909786A1 (tr) | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Sefiksim içeren efervesan tablet ve granül formülasyonu. |
TR201010860A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Sefdinir formulasyonları için üretim yöntemi. |
TR201009167A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Sefalosporin içeren farmasötik granüller. |
JP6077555B2 (ja) * | 2012-02-15 | 2017-02-08 | 武田薬品工業株式会社 | 錠剤 |
EP2882423A1 (en) | 2012-08-07 | 2015-06-17 | Sandoz AG | Uncoated tablet comprising granules including a -lactam antibiotic and highly dispersed silicone dioxide |
CN105142617B (zh) | 2013-03-15 | 2018-08-03 | 布伦特里实验室公司 | 双用途硫酸盐口服药物组合物片剂及其使用方法 |
WO2015153841A1 (en) | 2014-04-04 | 2015-10-08 | Ritter Pharmaceuticals, Inc. | Methods and compositions for microbiome alteration |
KR102415876B1 (ko) * | 2014-04-21 | 2022-06-30 | 주식회사 다이셀 | 미소섬유상 셀룰로오스를 포함하는 붕해성 입자 조성물 |
US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10179109B2 (en) | 2016-03-04 | 2019-01-15 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
WO2019118984A2 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
EP3846830A4 (en) | 2018-09-05 | 2022-07-06 | Solarea Bio, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES |
US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
WO2020257722A2 (en) | 2019-06-19 | 2020-12-24 | Solarea Bio, Inc. | Microbial compositions and methods for producing upgraded probiotic assemblages |
CA3238788A1 (en) | 2021-11-22 | 2023-05-25 | Eric Michael Schott | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
DE2251250C3 (de) * | 1972-10-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten |
JPS5438167B2 (pt) * | 1974-04-27 | 1979-11-19 | ||
JPS5562012A (en) * | 1978-11-06 | 1980-05-10 | Teijin Ltd | Slow-releasing preparation |
JPS5620513A (en) * | 1979-07-31 | 1981-02-26 | Eisai Co Ltd | Sugar-coated tablet containing fat-soluble drug |
GB2058565B (en) * | 1979-09-21 | 1983-12-07 | Leo Pharm Prod Ltd | Layer tablets |
NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
DE3134591A1 (de) * | 1981-09-01 | 1983-03-10 | Bayer Ag, 5090 Leverkusen | Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren |
JPS5839618A (ja) * | 1981-09-04 | 1983-03-08 | Chugai Pharmaceut Co Ltd | 持続性積層錠剤 |
DE3266580D1 (en) * | 1981-12-02 | 1985-10-31 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4428951A (en) * | 1982-04-22 | 1984-01-31 | Fujisawa Pharmaceutical Co., Ltd. | Long acting pharmaceutical composition |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
JPS59101423A (ja) * | 1982-12-02 | 1984-06-12 | Takada Seiyaku Kk | 新規なニフエジピン固形製剤 |
JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
JPS6097919A (ja) * | 1983-11-01 | 1985-05-31 | Furointo Sangyo Kk | 圧縮成形用賦形剤の製造方法 |
NL8400911A (nl) * | 1984-03-22 | 1985-10-16 | Dagra Nv | Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat. |
GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
US4753801A (en) * | 1985-10-25 | 1988-06-28 | Eli Lilly And Company | Sustained release tablets |
US4851233A (en) * | 1986-10-06 | 1989-07-25 | Warner-Lambert Company | Sustained release formulations |
US4837030A (en) * | 1987-10-06 | 1989-06-06 | American Cyanamid Company | Novel controlled release formulations of tetracycline compounds |
-
1988
- 1988-02-26 ES ES88200366T patent/ES2061623T3/es not_active Expired - Lifetime
- 1988-02-26 DE DE3887179T patent/DE3887179T2/de not_active Expired - Lifetime
- 1988-02-26 EP EP88200366A patent/EP0281200B1/en not_active Expired - Lifetime
- 1988-02-29 FI FI880928A patent/FI94214C/fi active IP Right Grant
- 1988-03-01 PT PT86870A patent/PT86870B/pt active IP Right Grant
- 1988-03-01 DK DK198801088A patent/DK175508B1/da not_active IP Right Cessation
- 1988-03-01 AU AU12520/88A patent/AU603870B2/en not_active Expired
- 1988-03-01 NO NO880904A patent/NO174996C/no not_active IP Right Cessation
- 1988-03-01 IL IL85594A patent/IL85594A/xx not_active IP Right Cessation
- 1988-03-02 IE IE58488A patent/IE70907B1/en not_active IP Right Cessation
- 1988-03-02 NZ NZ223711A patent/NZ223711A/xx unknown
- 1988-03-02 CA CA000560356A patent/CA1338467C/en not_active Expired - Lifetime
- 1988-03-02 KR KR1019880002170A patent/KR960009182B1/ko not_active IP Right Cessation
- 1988-03-02 JP JP63049440A patent/JPS63301820A/ja active Pending
- 1988-03-02 US US07/162,834 patent/US4950484A/en not_active Expired - Lifetime
- 1988-03-02 CN CN88101104A patent/CN1036763C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL85594A (en) | 1992-11-15 |
FI94214B (fi) | 1995-04-28 |
JPS63301820A (ja) | 1988-12-08 |
NO174996B (no) | 1994-05-09 |
CN88101104A (zh) | 1988-12-21 |
CN1036763C (zh) | 1997-12-24 |
NO174996C (no) | 1994-08-17 |
DK175508B1 (da) | 2004-11-15 |
FI94214C (fi) | 1995-08-10 |
PT86870B (pt) | 1992-05-29 |
FI880928A0 (fi) | 1988-02-29 |
AU603870B2 (en) | 1990-11-29 |
US4950484A (en) | 1990-08-21 |
DE3887179D1 (de) | 1994-03-03 |
IE880584L (en) | 1988-09-02 |
DK108888D0 (da) | 1988-03-01 |
NO880904D0 (no) | 1988-03-01 |
KR960009182B1 (ko) | 1996-07-16 |
DK108888A (da) | 1988-09-03 |
AU1252088A (en) | 1988-09-01 |
FI880928A (fi) | 1988-09-03 |
ES2061623T3 (es) | 1994-12-16 |
CA1338467C (en) | 1996-07-23 |
NZ223711A (en) | 1989-08-29 |
DE3887179T2 (de) | 1994-06-16 |
IE70907B1 (en) | 1997-01-15 |
NO880904L (no) | 1988-09-05 |
KR880010757A (ko) | 1988-10-24 |
EP0281200B1 (en) | 1994-01-19 |
EP0281200A1 (en) | 1988-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86870A (pt) | Pharmaceutical tablet pharmaceutical granulate and process for their preparation | |
HUT54491A (en) | Quickly soluble pharmaceutical unit dosage and process for producing same | |
DK89090D0 (da) | Farmaceutisk praeparat | |
NO177038C (no) | Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem | |
GB2149413B (en) | Sustained release pharmaceutical tablets and process for the preparation thereof | |
LV10184A (lv) | Tabletejama medikamenta izgatavosanas panemiens | |
HUT51272A (en) | Process for producing thiadiazin derivatives and pharmaceutical composirions containing them | |
ATA119188A (de) | Pharmazeutische granulate und verfahren zu ihrer herstellung | |
PT86986A (pt) | Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments | |
DK705488D0 (da) | Farmaceutisk praeparat | |
PT87237A (pt) | Process for the preparation of bifunctional proteins and of pharmaceutical compounds containing them | |
DK287188D0 (da) | Cephalosporinforbindelser og farmaceutisk praeparat deraf | |
PT87243A (pt) | Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them | |
EP0347748A3 (en) | Pharmaceutical granules and tablets made therefrom | |
DK96394A (da) | 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf | |
NO176746C (no) | Fremgangsmåte for fremstilling av en tablett med sympatomimetikum og piperidinoalkanol i adskilte soner | |
DK139388D0 (da) | Farmaceutisk praeparat | |
DK259586A (da) | Farmaceutisk tablet | |
DK276288D0 (da) | Farmaceutisk praeparat | |
PT86642A (pt) | Arylthiadiazolylsulfonamides and derivatives a process for thir preparation and their use as medicaments | |
PT87593A (pt) | Process for the preparation of nucleosides and of pharmaceutical compounds containing them | |
AU106236S (en) | Pharmaceutical tablet | |
FR2609246B3 (fr) | Produits cosmetiques a base de spiruline et leur procede de preparation | |
DK580288D0 (da) | Farmaceutisk praeparat indeholdende imidazol-2-thioncarboxamider | |
PT87573A (pt) | Process for the preparation of amidas pyrazine and of pharmaceutical compounds containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19911127 |
|
PC3A | Transfer or assignment |
Free format text: 920416 BROCADES PHARMA B.V. NL |
|
PD3A | Change of proprietorship |